---
$id: https://graph.org.ai/products/commodity/51413907
$type: Product
source: UNSPSC
code: "51413907"
title: "Manozodil"
class: "51413900"
classTitle: "Vasodilators, synthesized"
family: "51410000"
familyTitle: "Vasodilators"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Manozodil

**UNSPSC Code**: 51413907
**Class**: [Vasodilators, synthesized](Vasodilators, synthesized.mdx)
**Family**: [Vasodilators](../Vasodilators.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a vasodilating agent with the molecular formula C10H16N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GZM2484VQ4, chemically known as 4,5,6,7-tetrahydro-2-methyl-5-((methylamino)methyl)benzothiazole but generally known as manozodil, which bears US NIH Compound Identifier 72110. European Medicines Agency schedules Manozodil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08645MIG. The term MANOZODIL is an International Non-Proprietary Name. MANOZODIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule manozodil under HS 29341000 and SITC 51579. As of Q4 2014, MANOZODIL remains the US FDA Preferred Term for this commodity. Manozodil bears US NLM identifiers UMLS ID C2698013 and NCI Concept Code C74415. SMILES: CC1=NC2=C(S1)CCC(C2)CNC.

